Zhangzhou Pientzehuang Pharmaceutical Stock Current Valuation
600436 Stock | 232.46 3.04 1.29% |
Valuation analysis of Zhangzhou Pientzehuang helps investors to measure Zhangzhou Pientzehuang's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At present, Zhangzhou Pientzehuang's Cash is projected to increase significantly based on the last few years of reporting. The current year's Total Cash From Operating Activities is expected to grow to about 2.3 B, whereas Other Cashflows From Financing Activities is forecasted to decline to about 17.7 M. Fundamental drivers impacting Zhangzhou Pientzehuang's valuation include:
Price Book 10.0024 | Enterprise Value 138.2 B | Enterprise Value Ebitda 37.3678 | Price Sales 12.9181 | Trailing PE 45.89 |
Fairly Valued
Today
Please note that Zhangzhou Pientzehuang's price fluctuation is very steady at this time. Calculation of the real value of Zhangzhou Pientzehuang is based on 3 months time horizon. Increasing Zhangzhou Pientzehuang's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Zhangzhou Pientzehuang is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Zhangzhou Stock. However, Zhangzhou Pientzehuang's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 232.46 | Real 233.12 | Hype 233.71 | Naive 219.88 |
The real value of Zhangzhou Stock, also known as its intrinsic value, is the underlying worth of Zhangzhou Pientzehuang Company, which is reflected in its stock price. It is based on Zhangzhou Pientzehuang's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Zhangzhou Pientzehuang's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Zhangzhou Pientzehuang Pharmaceutical helps investors to forecast how Zhangzhou stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Zhangzhou Pientzehuang more accurately as focusing exclusively on Zhangzhou Pientzehuang's fundamentals will not take into account other important factors: Zhangzhou Pientzehuang Pharmaceutical Company Current Valuation Analysis
Zhangzhou Pientzehuang's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Zhangzhou Pientzehuang Current Valuation | 138.15 B |
Most of Zhangzhou Pientzehuang's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Zhangzhou Pientzehuang Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition |
In accordance with the recently published financial statements, Zhangzhou Pientzehuang Pharmaceutical has a Current Valuation of 138.15 B. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all China stocks is notably lower than that of the firm.
Zhangzhou Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Zhangzhou Pientzehuang's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Zhangzhou Pientzehuang could also be used in its relative valuation, which is a method of valuing Zhangzhou Pientzehuang by comparing valuation metrics of similar companies.Zhangzhou Pientzehuang is currently under evaluation in current valuation category among its peers.
Zhangzhou Fundamentals
Return On Equity | 0.22 | ||||
Return On Asset | 0.13 | ||||
Profit Margin | 0.28 % | ||||
Operating Margin | 0.39 % | ||||
Current Valuation | 138.15 B | ||||
Shares Outstanding | 603.32 M | ||||
Shares Owned By Insiders | 63.67 % | ||||
Shares Owned By Institutions | 6.77 % | ||||
Price To Book | 10.00 X | ||||
Price To Sales | 12.92 X | ||||
Revenue | 10.06 B | ||||
Gross Profit | 3.96 B | ||||
EBITDA | 3.6 B | ||||
Net Income | 2.78 B | ||||
Total Debt | 989.93 M | ||||
Book Value Per Share | 23.24 X | ||||
Cash Flow From Operations | 2.21 B | ||||
Earnings Per Share | 5.09 X | ||||
Target Price | 272.37 | ||||
Number Of Employees | 2.79 K | ||||
Beta | 0.8 | ||||
Market Capitalization | 140.92 B | ||||
Total Asset | 17.08 B | ||||
Retained Earnings | 10 B | ||||
Working Capital | 12.22 B | ||||
Net Asset | 17.08 B | ||||
Last Dividend Paid | 2.32 |
About Zhangzhou Pientzehuang Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Zhangzhou Pientzehuang Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zhangzhou Pientzehuang using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zhangzhou Pientzehuang Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Zhangzhou Stock
Zhangzhou Pientzehuang financial ratios help investors to determine whether Zhangzhou Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zhangzhou with respect to the benefits of owning Zhangzhou Pientzehuang security.